OPEN-SOURCE SCRIPT
Aquantprice: Institutional Structure Matrix


Why This is the Final Dashboard You’ll Ever Need:
Multi-Timeframe Trend Validators (1min to Monthly): 15 buy / 13 sell conditions using CPR pivots, weighted closes, and Camarilla logic — signals "BUY"/"SELL" only when threshold met.
Dip Buying & Sell Validators (Daily/Weekly/Monthly): 15-condition engine with ✔/✖ breakdown for long-term swing precision.
Two-Day Pivot Dashboard: Tracks CPR, POC, VAH/VAL, H3/L3 + exclusive two-day value shift ("Higher/Lower/Unchanged Value") — Pivot Boss on steroids.
Mind Over Markets Bias Engine: Detects "Initiative Buy/Sell," "Neutral," or "Rising Pivot, Weak Open" using rolling POC and neutral zone — pure institutional psychology.
Wick Reversal & Pattern Detection: Identifies Bull/Bear Wicks, Dojis, Outside Bars, and Extreme candles near pivot touches.
Risk-Reward & Target Projection: Auto-calculates RR ratios (min 2.0), next pivot targets, and entry zones (S1, R1, POC, etc.).
Quant Bias Summary: Weighted multi-TF aggregation delivers final verdict: Strong Buy → Buy → Neutral → Sell → Strong Sell.
Customizable Everything: Thresholds, timeframes, decimals, font size, table positions, novice mode — built for your style.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.